Xcout Intel
CytoImmune Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to CytoImmune Therapeutics, Inc. among biotechnology companies — ranked by similarity to what CytoImmune Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see CytoImmune Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CytoImmune Therapeutics, Inc.
CytoImmune Therapeutics is a clinical-stage biotechnology company headquartered in Duarte, California, focused on developing novel cell therapies for cancer treatment.
CytoImmune Therapeutics, Inc. at a glance
CytoImmune Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $36.5M in July 2021. Xcout tracks 7 named people at CytoImmune Therapeutics, Inc., including Christina Coughlin, M.D., Ph.D. (CEO of CytoImmune Therapeutics, Inc.).
CytoImmune Therapeutics, Inc. leadership
- Christina Coughlin, M.D., Ph.D.CEO of CytoImmune Therapeutics, Inc.
- Jose Vidal, Ph.D.Chief Operating Officer
- Richard T SantulliCo-founder and Chairman of CytoImmune Therapeutics, former founder and CEO of NetJets, Inc.
- Michael A. Caligiuri, M.D.Co-Founder & Chief Scientific Officer
- Ivone Bruno, Ph.D.VP, Preclinical Affairs and Process Development
- Tania Rodriguez, Ph.D.Director of Research & Process Development
1 more named person on record for CytoImmune Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
CytoImmune Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $36.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CytoImmune Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to CytoImmune Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
SystImmune, Inc. is a clinical-stage bio-pharmaceutical company founded in 2014 and located in Redmond, Washington. The company is focused on the treatment of cancer through developing novel therapeutics and biopharmaceuticals.
Similar biotechnology company
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Biotech
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Similar biotechnology company
Noile-Immune Biotech Inc. is a biotechnology company incorporated in 2015 and headquartered in Tokyo, Japan. The company specializes in the development of next-generation cancer immunotherapies, including advanced CAR-T cell technologies.
Life Sciences
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Similar biotechnology company
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Similar biotechnology company
Kite is a global biopharmaceutical company based in Santa Monica, California, that specializes in developing innovative cell therapies to treat and potentially cure cancer.
Similar biotechnology company
Q-Immune, Inc. provides real-time protein network analysis for CAR-T cells to predict efficacy, optimize CAR-T design, and improve immunotherapy outcomes. The company serves researchers and developers in oncology, autoimmune, and neuroscience fields by generating data to model and predict cellular behavior.
Biotech
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
Similar biotechnology company
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Similar biotechnology company
Carisma Therapeutics is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on discovering and developing engineered macrophage-based immunotherapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CytoImmune Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CytoImmune Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →